Diagnosis: Anxiety
Treatment: Brand Xanax

Summary:
The patient is a female. The physician writes that the patient has been taking Xanax. He writes that the generic form "failed." He also writes that Ativan, clonazepam, and diazepam did not alleviate the patient's anxiety.

The provider does not provide any details regarding the reported "failure" of the proposed generic formulation. There is no evidence regarding dosage, specific symptoms, clinical description of patient response, duration of treatment, etc. There is no adequate clinical description that would meet generally accepted criteria.

Thus, the health plan's requirements that the patient must have had a severe reaction to the generic drug, that switching to the generic agent would worsen the patient's condition and require urgent medical care, or that the patient might require additional medical treatment as a result, are reasonable and are not met.